LSBio IHC-plus antibodies

Friday, 04 March, 2022 | Supplied by: Sapphire Bioscience


LSBio’s IHC-plus antibodies have been tested and identified as being optimal for use in immunohistochemistry (IHC) against formalin-fixed paraffin-embedded (FFPE) human tissues under LSBio’s standardised IHC-plus immunohistochemistry protocol. Each antibody is tested at multiple concentrations on more than 20 normal human tissue types and, when appropriate, multiple normal brain regions and/or cancer types.

The company’s IHC protocol has been developed over the past 15 years for immunolabelling FFPE tissues, the most common fixation method used by pathology labs worldwide. A LifeSpan pathologist, with extensive experience evaluating IHC, analyses the localisation profile of each antibody, identifying positive and negative cell types, signal strength, subcellular and extracellular staining, and staining artefacts. This information is then compared with all published expression and localisation data available for the protein. This enables LSBio to evaluate how each antibody behaves in IHC, including its specificity to the target protein, its sensitivity of detection and any non-specific staining characteristics that it may display.

In order to be selected as an IHC-plus brand antibody, antibodies must have a close correlation to the published literature, be high affinity, display minimal staining artefacts and have a high signal-to-noise ratio, such that its specific staining is considerably higher than its level of nonspecific background staining.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...

BioStatus CyTRAK Orange fluorescent dye

BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd